159 related articles for article (PubMed ID: 3891417)
1. Advances in the clinical development of antiepileptic drugs.
Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG
Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417
[TBL] [Abstract][Full Text] [Related]
2. The Antiepileptic Drug Development Program: an example of government-industry collaboration.
White BG
Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic drug development program.
Porter RJ
Prog Clin Biol Res; 1983; 127():53-66. PubMed ID: 6351101
[TBL] [Abstract][Full Text] [Related]
4. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy.
White HS; Wolf HH; Woodhead JH; Kupferberg HJ
Adv Neurol; 1998; 76():29-39. PubMed ID: 9408461
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial design for antiepileptic drugs.
Cereghino JJ
Ann Neurol; 1992 Sep; 32(3):393-4. PubMed ID: 1416809
[No Abstract] [Full Text] [Related]
6. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M
Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
[TBL] [Abstract][Full Text] [Related]
7. The preclinical new drug research program of the National Cancer Institute.
Driscoll JS
Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
[TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs.
Chadwick D
Q J Med; 1994 Mar; 87(3):139-41. PubMed ID: 8208901
[No Abstract] [Full Text] [Related]
9. Antiepileptic drugs: future development.
Porter RJ
Epilepsy Res Suppl; 1993; 10():69-77. PubMed ID: 7504494
[TBL] [Abstract][Full Text] [Related]
10. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review.
Löscher W
Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):531-47. PubMed ID: 6439966
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods.
Browne TR
Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105
[No Abstract] [Full Text] [Related]
12. Guidelines for clinical evaluation of antiepileptic drugs. Commission on Antiepileptic Drugs of the International League Against Epilepsy.
Epilepsia; 1989; 30(4):400-8. PubMed ID: 2752994
[No Abstract] [Full Text] [Related]
13. Approaches to the development and marketing approval of drugs that prevent cancer.
Kelloff GJ; Johnson JR; Crowell JA; Boone CW; DeGeorge JJ; Steele VE; Mehta MU; Temeck JW; Schmidt WJ; Burke G
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):1-10. PubMed ID: 7894318
[TBL] [Abstract][Full Text] [Related]
14. Historical background of the National Cancer Institute's drug development thrust.
Zubrod CG; Schepartz SA; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156
[No Abstract] [Full Text] [Related]
15. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
16. Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice.
Fed Regist; 1998 Jun; 63(105):30002-5. PubMed ID: 10180274
[TBL] [Abstract][Full Text] [Related]
17. Methodology of clinical trials on new drugs in epilepsy.
Morselli PL
Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
[TBL] [Abstract][Full Text] [Related]
18. History of the antiepileptic drugs.
Swinyard EA
Adv Neurol; 1980; 27():1-9. PubMed ID: 6990700
[No Abstract] [Full Text] [Related]
19. A new look at the second-generation antiepileptic drugs: a decade of experience.
LaRoche SM
Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757
[TBL] [Abstract][Full Text] [Related]
20. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
